Cephalexin 125 mg/5ml

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, Respiratory Tract

Phase 1

Bioequivalence Study of Cephalexin Suspension 250

CompletedNCT01767571

GlaxoSmithKlineInfections, Respiratory Tract

Start: 2011-01-30End: 2011-02-08Updated: 2017-06-05

Bioequivalence Study of Cephalexin Suspension 125

CompletedNCT01767532

GlaxoSmithKlineInfections, Respiratory Tract

Start: 2011-01-30End: 2011-02-08Updated: 2017-06-22